Astellas Pharma's total assets for Q3 2022 were ¥2.51T, a decrease of -2.70% from the previous quarter. ALPMF total liabilities were ¥― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.